Eligibility Pre-Screening

A Study of Dabrafenib Plus Cetuximab/Panitumumab With FOLFOX in the First Line of Therapy in People With Metastatic Colorectal Cancer

This is a simplified pre-screening tool. Your answers help estimate whether you might qualify, but only the research team can confirm your eligibility. This is not medical advice.

Question 1 of 80%

1.Have you been diagnosed with colorectal cancer that has spread to other organs (metastatic colorectal cancer)?

Press Y/N or 1/2